Since 2003, SourceOne has been a provider of health and wellness solutions to leading medical, healthcare, and pharmacy brands around the world. We have established a global reputation for delivering novel formulations that are created through scientific research and innovative product development.
SourceOne Global Partners announced the launch of LysOmega®, a proprietary omega-3 formulation designed to increase levels of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) omega-3 essential fatty acids in the brain, retina, testes, and other vital organs via the MFSD2A transporter.
The LysOmega® study is designed to generate human pharmacokinetic and biomarker data evaluating whether the formulation produces higher and more consistent circulating DHA and EPA levels, and greater CNS availability of DHA and EPA, than conventional omega-3 products.
The LysOmega® formulation is powered by VESIsorb® technology and represents a first-to-market opportunity with an LPC-rich omega-3® formula validated for compatibility with a clinically proven drug delivery system.
Prior research suggests VESIsorb® technology will deliver higher LPC-omega-3 levels in the plasma, leading to a higher concentration of LPC-omega-3 at the MFSD2A transporter surface, which may in turn result in higher concentrations of LPC-omega-3 in the central nervous system (CNS).
Our focus is on clinically proven formulations, combined with technologically-advanced and patented delivery systems with applications in nutritional supplements, functional food and beverage, medical food, and personal care markets. The formulations are bundled in easily identifiable platforms that address condition-specific, consumer health concerns.
DISCOVER More
SourceOne has distinguished itself as a premier innovator of scientifically proven natural products and technologies. Our leadership team’s ongoing success in forging numerous global natural ingredient supply partnerships and research and development alliances results in competitive advantages and added value to the natural product portfolio we bring to the global marketplace.
The synergies created by these partnerships are directly and immediately applicable to the pioneering nutrition and health supplement products we are introducing and those we are developing. The many benefits derived from these innovations will resonate with our brand partners and ultimately the consumers and healthcare professionals focused on superior health and wellness solutions.
SourceOne's network of research and technology partners is bolstered by our longstanding relationship with Vesifact AG (Zürich, Switzerland), recognized as a global pioneer in drug delivery system solutions. The leadership teams at SourceOne and Vesifact have been working together since since 2005 to pioneer enhanced bioavailability of science-backed natural ingredients. Together, we have successfully commercialized more than 50 VESIsorb® formulations in all six major continents.
SourceOne has remained a leader in our industry for delivering novel formulations that you can't find anywhere else. It's understood that we will receive the highest level of customer service from SourceOne in addition to science-backed formulations that we are proud to include in our product portfolio. It's rare that an organization can provide such broad value from formulations and clinical research to marketing and executive communication.
When I think of innovative science-backed products, I think of SourceOne. Their leadership position is based on a reputation that they are not just offering commodities, but rather delivering innovation that has science behind it and clinical research done on the products and technologies that SourceOne provides.
It has always been very appealing working with SourceOne. They bring to you very novel technologies and things that are very timely. SourceOne is strategically focused on best-in-class, new innovations. One of the specialties of SourceOne is its ability to deliver on the early brainstorming ideas with real, science-backed solutions.
Natural products utilizing VESIsorb® have historically set the benchmark for delivering superior absorption and blood plasma levels that allow the body to use more of the active ingredients. This provides confidence that health conscious consumers will receive the maximum benefits from the key active ingredients that are found in our products.
SourceOne has the most advanced, clinically proven natural products available. They own an unrivaled position to deliver well-researched formulations that ensure optimal bioavailability of key ingredients. This is such a critical component of taking supplements and medicines as consumers need to understand the importance of absorption - and no one answers this calling as well as SourceOne.
Throughout my career, it has been rare to find a company that has the core values and competencies that SourceOne possesses. Their integrity to introduce science-backed formulations over the past 20 years has been unmatched. We believe strongly in building relationships with our supply partners, and SourceOne has never wavered in its commitment to build a long term partnership built on trust, respect, and quality products.
Geocann's network of research and technology partners is bolstered by our longstanding relationship with Vesifact AG (Zürich, Switzerland), recognized as a global pioneer in drug delivery system solutions. The leadership teams at Geocann and Vesifact have been working together since 2005 and have successfully commercialized more than 50 VESIsorb® formulations in all six major continents.
Watch the following video to learn more about Vesifact.